Geron to Announce Third Quarter 2018 Financial Results on November 1, 2018
October 25 2018 - 6:00AM
Geron Corporation (Nasdaq: GERN) today announced that it will
release its third quarter 2018 financial results after the market
closes on Thursday, November 1, 2018. The financial press release
will be available on the Company’s website at
www.geron.com/investors. Geron will host a conference call to
discuss the third quarter results and recent events at 4:30 p.m. ET
the same day.
Participants may access the conference call live via telephone
by dialing domestically +1 (877) 303-9139 or internationally +1
(760) 536-5195. The passcode is 7133129. Participants are advised
to dial in at least 10 minutes prior to minimize any delay in
joining the call. A live, listen-only webcast will also be
available on the Company’s website at
www.geron.com/investors/events. If you are unable to listen to the
live call, an archived webcast will be available on the Company’s
website for 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on
the development and potential commercialization of a first-in-class
telomerase inhibitor, imetelstat, in hematologic myeloid
malignancies. For more information about Geron, visit
www.geron.com.
CONTACT:
Suzanne MessereInvestor and Media Relationsinvestor@geron.com
media@geron.com
CG Capital877-889-1972
Geron (NASDAQ:GERN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Sep 2023 to Sep 2024